InvestorsHub Logo

williamssc

11/27/17 1:23 PM

#131951 RE: TomP1 #131949

Could be that they see something in the molecules that may pair with some lab study. They are taking a low ball chance in my opinion.

Reyeton

11/27/17 1:51 PM

#131956 RE: TomP1 #131949

Seems to me BIIB is only interested in drugs that treat disease symptoms not drugs that target causes of diseases. Anavex doesn’t fit into their $business$ strategy. I believe Anavex is a company whose strategy truly puts patients before profits.